Sustabolic – Testosterone Blend 250 mg/mL | 10 mL Vial
1. Product Overview
Sustabolic is presented as an injectable anabolic-androgenic steroid preparation containing a combination of four testosterone esters.
According to the supplied Roidsdeal short description, the formulation contains testosterone propionate, testosterone phenylpropionate, testosterone isocaproate, and testosterone decanoate.
The product has a declared combined concentration of 250 mg/mL and is packaged in a 10 mL vial.
Based on these specifications, the calculated total combined testosterone ester content is 2,500 mg per vial.
However, the supplied description does not specify the individual concentration of each testosterone ester.
Therefore, the amount contributed by each ester cannot be established from the available information.
Testosterone is a naturally occurring androgen involved in male reproductive physiology, secondary sexual characteristics, and other androgen-responsive biological processes.
Testosterone ester preparations are designed to release testosterone following ester hydrolysis.
Different testosterone esters have different physicochemical and pharmacokinetic characteristics.
Combining several esters can produce a formulation with multiple release components.
However, the exact pharmacokinetic profile depends on the individual ester concentrations, carrier vehicle, formulation, and other factors.
The supplied information identifies Nitro Labs as the manufacturer.
No original manufacturer label or independent documentation has been provided to confirm this identity.
The available material also does not establish that Sustabolic is an authorized pharmaceutical product.
This description provides an educational overview of the declared testosterone ester blend, its pharmacological characteristics, medical context, and relevant safety limitations.
2. What Is Sustabolic?
Sustabolic is the commercial product name used for a four-ester testosterone preparation described in the supplied Roidsdeal product data.
The declared active ingredients are:
Testosterone Propionate
Testosterone propionate is an esterified form of testosterone associated with relatively shorter release characteristics compared with longer-chain testosterone esters.
Testosterone Phenylpropionate
Testosterone phenylpropionate is another esterified testosterone preparation with pharmacokinetic characteristics that differ from testosterone propionate and longer-chain esters.
Testosterone Isocaproate
Testosterone isocaproate is an esterified form of testosterone used in certain multi-ester testosterone preparations.
Testosterone Decanoate
Testosterone decanoate is a longer-chain testosterone ester associated with more prolonged release characteristics in appropriately formulated injectable preparations.
These four ingredients share testosterone as the pharmacologically active hormone following ester hydrolysis.
The ester groups influence release and absorption characteristics.
The supplied product is described as containing a combined 250 mg/mL of testosterone esters.
This value represents the declared combined ester mass, not necessarily 250 mg/mL of free testosterone.
The precise amount of testosterone released from the ester mixture depends on the identity and proportions of the individual esters.
Because the individual ester concentrations have not been provided, the total free-testosterone-equivalent content cannot be calculated reliably.
3. How Does the Testosterone Blend Work?
Sustabolic is described as a mixture of four testosterone esters.
Testosterone Ester Hydrolysis
Testosterone esters are chemically modified forms of testosterone.
Following release from an appropriately formulated preparation, ester hydrolysis produces testosterone.
The released testosterone can then participate in normal androgen-related biological pathways.
Androgen Receptor Activation
Testosterone interacts with androgen receptors in hormone-responsive tissues.
These receptors regulate gene expression and participate in physiological processes involving reproductive function, muscle, bone, and other tissues.
Different Ester Characteristics
The four declared esters have different physicochemical properties.
These differences influence their release characteristics in appropriately formulated preparations.
However, the exact release profile of Sustabolic cannot be established without knowing the individual ester concentrations and formulation details.
Conversion to Dihydrotestosterone
Testosterone can be converted into dihydrotestosterone (DHT) through 5-alpha-reductase activity.
DHT is an androgen involved in several hormone-responsive tissues.
Conversion to Estradiol
Testosterone can undergo aromatization into estradiol.
Estradiol participates in multiple physiological processes, including aspects of bone health and reproductive endocrine regulation.
However, excessive or inappropriate androgen exposure can disrupt hormonal balance.
Endocrine Feedback
Exogenous testosterone can suppress hypothalamic-pituitary-gonadal axis activity.
This may reduce endogenous testosterone production and impair sperm production.
Formulation-Dependent Pharmacokinetics
The pharmacokinetic characteristics of a testosterone ester blend depend on the relative proportions of its ingredients, the carrier vehicle, and other formulation characteristics.
Because these details are not supplied, no product-specific onset, peak, or duration of action can be established.
4. Medical Uses & Clinical Information
Testosterone preparations have established medical applications in appropriately diagnosed conditions.
However, the clinical authorization of specific testosterone medicines does not establish that Sustabolic is an approved pharmaceutical product.
Testosterone Deficiency
Certain authorized testosterone preparations are prescribed for individuals with clinically established testosterone deficiency due to specific medical conditions.
Diagnosis and treatment require appropriate medical assessment.
Male Hypogonadism
Testosterone replacement therapy may be indicated in selected patients with confirmed hypogonadism.
However, treatment suitability depends on the underlying diagnosis, clinical findings, and applicable prescribing information.
Androgen Receptor Research
Testosterone is extensively studied for its effects on androgen receptor signaling.
These pathways are relevant to reproductive physiology, endocrine function, muscle, and bone metabolism.
Bone and Muscle Physiology
Testosterone participates in physiological processes involving bone maintenance and muscle tissue.
However, these biological roles do not establish that nonmedical anabolic steroid use is safe or appropriate.
Reproductive Endocrinology
Exogenous testosterone can suppress endogenous gonadotropin signaling and interfere with normal sperm production.
This is an important consideration in individuals concerned about fertility.
Cardiovascular and Hematological Effects
Testosterone exposure can influence hematocrit, hemoglobin, blood pressure, and other physiological parameters.
Excessive erythrocytosis and cardiovascular complications are relevant safety concerns.
Multi-Ester Testosterone Preparations
Certain authorized testosterone medicines contain combinations of testosterone esters.
However, the existence of authorized multi-ester formulations does not establish that Sustabolic has the same ingredient proportions, manufacturing quality, clinical performance, or regulatory status.
Performance-Enhancement Claims
Testosterone and its esters are sometimes discussed in bodybuilding and athletic performance contexts.
However, nonmedical performance enhancement is not an established safe medical indication.
Testosterone and its esters are prohibited in competitive sport under WADA regulations.
Clinical Limitations
No product-specific clinical studies evaluating Sustabolic have been supplied.
The available information does not establish its bioequivalence to any authorized testosterone preparation.
Therefore, established medical research involving testosterone should not be interpreted as proof of the safety or effectiveness of this commercial product.
5. Product Specifications & Packaging
| Specification | Details |
|---|---|
| Product Name | Sustabolic |
| Brand | Not Independently Confirmed |
| Listed Manufacturer | Nitro Labs |
| Manufacturer Verification | Required |
| Active Ingredient 1 | Testosterone Propionate |
| Active Ingredient 2 | Testosterone Phenylpropionate |
| Active Ingredient 3 | Testosterone Isocaproate |
| Active Ingredient 4 | Testosterone Decanoate |
| Compound Classification | Anabolic-Androgenic Steroid |
| Chemical Classification | Esterified Testosterone Blend |
| Declared Combined Concentration | 250 mg/mL |
| Individual Ester Concentrations | Not Specified |
| Dosage Form | Injectable Preparation |
| Declared Package Volume | 10 mL |
| Packaging Presentation | Vial |
| Calculated Total Combined Ester Content | 2,500 mg |
| Free Testosterone Equivalent | Cannot Be Determined |
| Carrier Oil / Vehicle | Not Specified |
| Excipients | Not Specified |
| Product Category | Injectable Anabolic Steroids |
| Aromatization | Testosterone Can Aromatize into Estradiol |
| US Controlled Substance Status | Schedule III |
| WADA Status | Prohibited |
| Product-Specific Regulatory Approval | Not Established |
| Batch-Specific COA | Not Provided |
| Sterility Testing | Not Provided |
| Actual Ingredient Concentrations | Not Independently Verified |
| Manufacturing Quality | Not Independently Verified |
The supplied Roidsdeal short description identifies four testosterone esters.
However, it does not specify how the combined 250 mg/mL concentration is distributed among them.
The following information is therefore unavailable:
- Testosterone Propionate: Individual mg/mL not specified
- Testosterone Phenylpropionate: Individual mg/mL not specified
- Testosterone Isocaproate: Individual mg/mL not specified
- Testosterone Decanoate: Individual mg/mL not specified
The formulation should not be assumed identical to any other four-ester testosterone product.
No manufacturer-specific analytical report, sterility testing, or complete formulation documentation has been supplied.
6. Administration & Medical Supervision
Sustabolic is described as an injectable testosterone ester blend.
However, the supplied documentation does not establish an approved human dosing regimen or authorized therapeutic indication for this specific product.
The declared 250 mg/mL concentration represents the claimed combined amount of testosterone esters per milliliter.
It does not represent a recommended or medically appropriate dose.
No injection procedure, administration schedule, bodybuilding cycle, or performance-enhancement regimen is supported by the supplied information.
The individual ester concentrations and exact formulation are unknown.
These limitations prevent reliable assessment of product-specific pharmacokinetic characteristics.
Medical evaluation of testosterone exposure may involve hematocrit, hemoglobin, blood pressure, lipid measurements, endocrine function, and other relevant clinical parameters.
The actual ingredient content, sterility, and pharmaceutical quality of this commercial product have not been independently verified.
It should not be assumed suitable for human injection based solely on the supplied short description.
7. Possible Side Effects & Safety Limitations
Testosterone ester preparations can produce adverse effects associated with androgen exposure.
Endocrine and Reproductive Effects
Potential adverse effects include:
- Suppression of endogenous testosterone production
- Reduced sperm production
- Reduced fertility
- Testicular atrophy
- Gynecomastia
- Other hormonal disturbances
Cardiovascular and Metabolic Effects
Potential complications include:
- Elevated blood pressure
- Fluid retention
- Adverse cholesterol changes
- Erythrocytosis
- Increased hematocrit
- Cardiovascular complications
Androgenic Effects
Potential androgen-related effects include:
- Acne
- Oily skin
- Hair loss in susceptible individuals
- Increased body or facial hair growth
- Prostate-related concerns in susceptible individuals
Effects in Females
Testosterone exposure can cause virilization.
Potential effects include voice deepening, increased facial hair, menstrual disturbances, and other androgenic characteristics.
Some changes may be irreversible.
Psychological and Behavioral Effects
Anabolic-androgenic steroid exposure may be associated with mood changes, irritability, and other behavioral disturbances.
Injectable Formulation Risks
Unverified injectable preparations may introduce additional risks involving:
- Microbial contamination
- Injection-site infection
- Incorrect ingredient concentrations
- Undisclosed excipients
- Formulation instability
- Sterility failures
The actual frequency and severity of adverse effects for this specific Sustabolic product have not been established.
8. Warnings & Precautions
Testosterone is a pharmacologically active androgen.
Exogenous testosterone exposure can alter normal endocrine regulation and suppress endogenous testosterone production.
Individuals with cardiovascular disease, abnormal hematocrit, prostate-related conditions, liver disorders, or reproductive-health concerns may face additional risks.
Testosterone can increase hematocrit and may contribute to erythrocytosis.
It can also influence blood pressure, fluid balance, and lipid metabolism.
Exposure during pregnancy may cause serious developmental harm.
Androgen exposure can cause virilization in females and interfere with normal development in adolescents.
Testosterone and its esters are prohibited in competitive sport under WADA regulations.
In the United States, testosterone is classified as a Schedule III controlled anabolic steroid.
The supplied description does not establish that Sustabolic is an authorized pharmaceutical preparation.
Product identity, individual ester concentrations, actual combined concentration, formulation, sterility, manufacturing quality, and regulatory authorization require independent verification.
9. Storage & Handling
Sustabolic is described as a 10 mL vial product.
The supplied information does not provide verified manufacturer-specific storage temperatures, stability data, or expiration requirements.
Storage conditions for injectable testosterone preparations depend on the carrier vehicle, excipients, container closure system, and manufacturing process.
These details are not supplied.
Storage should follow authentic manufacturer labeling when available.
The product should remain in its original, clearly identified packaging.
Avoid environmental conditions that may compromise formulation stability or packaging integrity.
Keep the product away from children and unauthorized access.
A vial with damaged packaging, compromised seals, uncertain labeling, or unverified storage history should not be assumed safe for administration.
No product-specific in-use stability information has been supplied.
10. Frequently Asked Questions (FAQs)
What is Sustabolic?
Sustabolic is a product described by Roidsdeal as containing four testosterone esters: propionate, phenylpropionate, isocaproate, and decanoate.
What is the declared combined concentration?
Roidsdeal lists a combined concentration of 250 mg/mL. The individual ester concentrations have not been provided.
What is the package size?
Roidsdeal identifies a 10 mL vial.
Is Sustabolic identical to Sustanon 250?
The four listed testosterone esters are also associated with certain Sustanon 250 formulations. However, the supplied information does not establish identical ester proportions, manufacturing standards, bioequivalence, or regulatory authorization.
Is Sustabolic an FDA-approved medication?
No FDA approval has been established for Sustabolic. The existence of authorized testosterone medicines does not establish regulatory authorization for this specific commercial product.
11. Conclusion & Medical Disclaimer
Sustabolic is presented as an injectable testosterone ester blend containing testosterone propionate, testosterone phenylpropionate, testosterone isocaproate, and testosterone decanoate.
According to Roidsdeal, the product has a declared combined concentration of 250 mg/mL and is packaged in a 10 mL vial.
The calculated total combined ester content is 2,500 mg per vial.
However, the individual ester concentrations have not been provided.
This prevents reliable determination of the formulation’s exact composition and free-testosterone-equivalent content.
The supplied information identifies Nitro Labs as the manufacturer but does not provide independent confirmation.
No Roidsdeal long description or Finest Gears product description is available.
Product authenticity, actual ingredient concentrations, carrier vehicle, sterility, manufacturing quality, and regulatory authorization remain unverified.
Medical Disclaimer: This information is provided for educational and product-identification purposes only. It does not constitute medical advice, injection guidance, dosage recommendations, or a recommendation for nonmedical anabolic steroid use, bodybuilding, athletic performance enhancement, or treatment of any medical condition.




Reviews
There are no reviews yet.